Paper36060964
Inside the Noonan "universe": Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns.
Stagi S and 4 others. Front Endocrinol (Lausanne), 2022. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Inside the Noonan "universe": Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns. Papers, record 36060964. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36060964
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inside the Noonan "universe": Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dwarfism, Pituitary | Major topic |
| Human Growth Hormone | Major topic |
| Noonan Syndrome | Major topic |
| Adolescent | |
| Body Height | |
| Child | |
| Humans | |
| Recombinant Proteins |
Source PubMed
References164
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17177115 | Noonan syndrome and related disorders: alterations in growth and puberty. | Rev Endocr Metab Disord | 2006 | https://conductscience.org/library/papers/17177115 | PubMed |
| 2 | 30481304 | Dominant Noonan syndrome-causing LZTR1 mutations specifically affect the Kelch domain substrate-recognition surface and enhance RAS-MAPK signaling. | Hum Mol Genet | 2019 | https://conductscience.org/library/papers/30481304 | PubMed |
| 3 | 8241645 | Long-term treatment with growth hormone in Noonan's syndrome. | Acta Paediatr | 1993 | https://conductscience.org/library/papers/8241645 | PubMed |
| 4 | 18562489 | Long-term GH treatment improves adult height in children with Noonan syndrome with and without mutations in protein tyrosine phosphatase, non-receptor-type 11. | Eur J Endocrinol | 2008 | https://conductscience.org/library/papers/18562489 | PubMed |
| 5 | 27168784 | An examination of the effects of different doses of recombinant human growth hormone on children with growth hormone deficiency. | Exp Ther Med | 2016 | https://conductscience.org/library/papers/27168784 | PubMed |
| 6 | 10666495 | Estrogen deficiency is a potential cause for osteopenia in adult male patients with Noonan's syndrome. | Calcif Tissue Int | 2000 | https://conductscience.org/library/papers/10666495 | PubMed |
| 7 | 10202309 | A 16-year-old male with Noonan's syndrome develops progressive scoliosis and deteriorating gait. | Pediatr Neurosurg | 1999 | https://conductscience.org/library/papers/10202309 | PubMed |
| 8 | 25420281 | RAS diseases in children. | Haematologica | 2014 | https://conductscience.org/library/papers/25420281 | PubMed |
| 9 | 17222357 | Noonan syndrome. | Orphanet J Rare Dis | 2007 | https://conductscience.org/library/papers/17222357 | PubMed |
| 10 | 22777296 | Response to growth hormone therapy in children with Noonan syndrome: correlation with or without PTPN11 gene mutation. | Horm Res Paediatr | 2012 | https://conductscience.org/library/papers/22777296 | PubMed |
| 11 | 18057963 | Tumor development in three patients with Noonan syndrome. | Eur J Pediatr | 2008 | https://conductscience.org/library/papers/18057963 | PubMed |
| 12 | 8627463 | Growth hormone treatment in Noonan syndrome: the National Cooperative Growth Study experience. | J Pediatr | 1996 | https://conductscience.org/library/papers/8627463 | PubMed |
| 13 | 28328117 | Noonan syndrome, PTPN11 mutations, and brain tumors. A clinical report and review of the literature. | Am J Med Genet A | 2017 | https://conductscience.org/library/papers/28328117 | PubMed |
| 14 | 27038324 | Nutritional aspects of Noonan syndrome and Noonan-related disorders. | Am J Med Genet A | 2016 | https://conductscience.org/library/papers/27038324 | PubMed |
| 15 | 35160209 | Feeding Problems in Patients with Noonan Syndrome: A Narrative Review. | J Clin Med | 2022 | https://conductscience.org/library/papers/35160209 | PubMed |
| 16 | 21882908 | Associated disorders of Chiari Type I malformations: a review. | Neurosurg Focus | 2011 | https://conductscience.org/library/papers/21882908 | PubMed |
| 17 | 34382536 | The added value of the electrocardiogram in Noonan syndrome. | Cardiol Young | 2022 | https://conductscience.org/library/papers/34382536 | PubMed |
| 18 | 31132774 | Impact of Growth Hormone Therapy on Adult Height in Patients with PTPN11 Mutations Related to Noonan Syndrome. | Horm Res Paediatr | 2019 | https://conductscience.org/library/papers/31132774 | PubMed |
| 19 | 30398108 | The Landscape of Protein Tyrosine Phosphatase (Shp2) and Cancer. | Curr Pharm Des | 2018 | https://conductscience.org/library/papers/30398108 | PubMed |
| 20 | 21396583 | Noonan syndrome and clinically related disorders. | Best Pract Res Clin Endocrinol Metab | 2011 | https://conductscience.org/library/papers/21396583 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42882023 | The Diverse Clinical Spectrum of Noonan Syndrome in Pediatric Endocrinology: From Classical to Atypical Phenotypes. | J Clin Med | 2026 | https://conductscience.org/library/papers/42882023 | PubMed |
| 42824961 | Clinical consensus guidelines for the management of Noonan syndrome in Japan. | Clin Pediatr Endocrinol | 2026 | https://conductscience.org/library/papers/42824961 | PubMed |
| 42457321 | [Multiple clinical effects of recombinant human growth hormone therapy]. | Zhongguo Dang Dai Er Ke Za Zhi | 2026 | https://conductscience.org/library/papers/42457321 | PubMed |
| 42051956 | Case Report: Possible improvement of near-adult height with PEG-rhGH and letrozole in a late-puberty boy with atypical Noonan syndrome and bone age/height age discrepancy: a novel therapy. | Front Pediatr | 2026 | https://conductscience.org/library/papers/42051956 | PubMed |
| 41898889 | Genetic Mutations Underlying Growth Impairment and Cardiomyopathies in Children: Molecular Mechanisms, Clinical Implications and Targeted Therapies. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/41898889 | PubMed |
| 41377439 | Novel use of placental growth hormone in managing intrauterine growth restriction in Noonan syndrome. | Ann Med Surg (Lond) | 2025 | https://conductscience.org/library/papers/41377439 | PubMed |
| 41325415 | EndoCompass Project: Research Roadmap for Growth Disorders. | Horm Res Paediatr | 2025 | https://conductscience.org/library/papers/41325415 | PubMed |
| 41255695 | Deficiency of anterior pituitary hormones in Noonan syndrome and its impact on response to growth hormone therapy. | World J Clin Pediatr | 2025 | https://conductscience.org/library/papers/41255695 | PubMed |
| 40041286 | Editorial: Endocrine aspects of Noonan syndrome and related syndromes, volume II. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40041286 | PubMed |
| 39825649 | [Growth and development patterns of Noonan syndrome and advances in the treatment of short stature]. | Zhongguo Dang Dai Er Ke Za Zhi | 2025 | https://conductscience.org/library/papers/39825649 | PubMed |
| 39337654 | The Effects of Growth Hormone Treatment Beyond Growth Promotion in Patients with Genetic Syndromes: A Systematic Review of the Literature. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39337654 | PubMed |
| 38802902 | [Safety considerations for the clinical application of recombinant human growth hormone]. | Zhongguo Dang Dai Er Ke Za Zhi | 2024 | https://conductscience.org/library/papers/38802902 | PubMed |
| 37568403 | Genotypic Findings in Noonan and Non-Noonan RASopathies and Patient Eligibility for Growth Hormone Treatment. | J Clin Med | 2023 | https://conductscience.org/library/papers/37568403 | PubMed |
| 37525886 | Noonan syndrome: rhGH treatment and PTPN11 mutation. | Mol Genet Genomic Med | 2023 | https://conductscience.org/library/papers/37525886 | PubMed |
| 36407105 | Modeling (not so) rare developmental disorders associated with mutations in the protein-tyrosine phosphatase SHP2. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/36407105 | PubMed |
Genes27
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36060964
GET https://conductscience.org/api/papers/v1/36060964/references?page=2